about
A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: an active and manageable regimen for stage IV squamous cell carcinoma of the head and neck.Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effectsNew chemoradiotherapy combinations in head and neck cancer.Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiationTechnical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicityIntensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivityInduction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.Evidence-based radiation oncology in head and neck squamous cell carcinoma.The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation.Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasmsImage guided hypofractionated radiotherapy by helical tomotherapy for prostate carcinoma: toxicity and impact on Nadir PSA.Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology.Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus.Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO).Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019.Quality indicators in the intensity modulated/image-guided radiotherapy era.Excellent survival regardless of disease stage in patients with advanced nasopharyngeal cancer.Co-culture with human fibroblasts increases the radiosensitivity of MCF-7 mammary carcinoma cells in collagen gels.Management of oropharyngeal mycosis in head and neck cancer occurring during (chemo) radiotherapy: an Italian radio-oncologist survey.Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the Choosing Treatment for Prostate Cancer (CHOICE) study.Integration of chemotherapy in an MFD--radiotherapy plan for advanced inoperable squamous cell carcinoma of the head and neck.Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database.Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.On-line optimization of intraoperative electron beam radiotherapy of the breast.The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation.Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.Corrigendum to "The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity" [Crit. Rev. Oncol./Hematol. 116 (2017) 82-88].Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.Complete response in a patient with gynecological hidradenocarcinoma treated with exclusive external beam radiotherapy and brachytherapy: a case report.Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters.Adjuvant intraoperative radiotherapy for selected breast cancers in previously irradiated women: Evidence for excellent feasibility and favorable outcomes.Treatment with cisplatin and fluorouracil alternating with radiation favourably affects prognosis of inoperable squamous cell carcinoma of the head and neck: results of a multivariate analysis on 273 patients.Preliminary experience using oncoplastic techniques of reduction mammaplasty and intraoperative radiotherapy: report of 2 cases.Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study.Hamming clustering techniques for the identification of prognostic indices in patients with advanced head and neck cancer treated with radiation therapy.
P50
Q33379326-3F2CC0EB-6EED-4BC4-8331-D3F098B56244Q33428284-525E5035-4D2B-4CE9-95A9-CDEC803F5433Q34408374-20D2B719-DF10-4842-BDDD-60F735DB177FQ34734253-4D9F8E59-727E-4871-A2E6-0EC107092189Q35268812-16BD2F01-1073-44BD-98EA-3C6650A83D54Q35534813-BE49E03F-256B-4466-8168-2C32F4F4F95DQ36010018-94969A38-B2E7-4B3A-B970-949A9F220E3EQ36105656-E90D5177-D3FF-46E2-B8B2-CD1314AC654AQ36621526-A73220D5-7E79-4A76-9E96-E10771F97D7DQ36812249-3143832E-C1FA-4780-A3CD-A358BF255307Q36993853-C7236179-63D2-45C7-B174-6D561D84767BQ37246757-3D892681-14D9-45B6-98C9-7FF024C80131Q37686861-29185AFF-29F4-4599-870A-61FFEF56C1A8Q38006297-DA2EDFFF-F3E4-4583-A897-3ECFA43EA022Q38357146-4B9C56C3-19A3-4792-9B86-F653C31026B9Q38383388-C251CD64-F1B2-4D13-9CD2-45D5BB6D2F54Q38947922-89060426-7459-469A-A113-991FCDC235A9Q39032882-9C165672-DC09-4248-83A4-7D23A9CC3F34Q39033390-9A6DA992-867E-45B2-81BE-8D4DFFF2261AQ40812166-F54E1ECA-39C2-4F01-9361-1B37AB33F328Q40896257-5D367563-B927-463A-A775-9A5CAFF67533Q41020465-0B2352B9-05F8-4DC5-8F59-799AEDBBEA6BQ41068116-E43C5645-54A2-46B5-A98B-0DBC6C78847FQ41430910-FB927C34-4C9D-48FC-8E87-70C16C35E222Q42017675-B1C8EF76-A5C8-4B21-B222-C08365773DDFQ43572060-07E15432-66F4-4E86-8CBC-8C247E42CF7EQ43891809-CC4E533C-DD0E-4584-920B-01293BDA97F5Q43952233-558472E9-5CDA-446A-9FFC-81338FD9F444Q46194368-9D912419-3D87-4ACE-88A9-DDF34F0EDF94Q46864533-A2010252-FAF5-48D3-B91C-5DF247AA69BCQ47238663-5058376F-71A9-4E74-86B6-32EFDEFC5066Q47904447-D5E97FA6-6099-414B-9B96-57A108077580Q48621553-743AC33E-7391-464A-88A3-9282859BD05CQ49634302-37D7A815-4CD2-42DF-8885-2FDF8B7E505FQ50076600-4B93DACC-8348-4695-8EC4-034EA7BF8D86Q50645097-5DD452DC-8C7B-4271-BB21-09802E935581Q50929856-F29CCAD7-EEEC-463C-8760-709B098D111EQ51034766-730112B1-7DEB-4B0E-9F47-0CF02B30691DQ51648451-21E1FA00-559B-43E0-979B-71B8153962FBQ52070713-E07F4E88-8AA3-486E-B5B0-87A9AF01864E
P50
description
researcher ORCID ID = 0000-0002-5001-4844
@en
name
Renzo Corvo
@ast
Renzo Corvo
@en
Renzo Corvo
@es
Renzo Corvo
@nl
type
label
Renzo Corvo
@ast
Renzo Corvo
@en
Renzo Corvo
@es
Renzo Corvo
@nl
prefLabel
Renzo Corvo
@ast
Renzo Corvo
@en
Renzo Corvo
@es
Renzo Corvo
@nl
P1153
7006335106
P31
P496
0000-0002-5001-4844